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Abstract
Background: DNA methylation has a central role in the epigenetic control of mammalian gene expression, and is
required for X inactivation, genomics imprinting and silencing of retrotransposons and repetitive sequences. Thus,
several technologies have been developed to measure the degree of DNA methylation.
Results: We here present the development of the detection of protein-protein interactions via the adaptation of
the proximity ligation in situ technology to evaluate the DNA methylation status in cells since the quantification of
Dnmt1/PCNA interaction in cells reflects the degree of DNA methylation.
Conclusion: This method being directly realizable on cells, it appears that it could suggest a wide range of
applications in basic research and drug development. More particularly, this method is specially adapted for the
investigations realized from a weak quantity of biologic materiel such as stem cells or primary cultured tumor cells
for examples.
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Background
DNA methylation has a central role in the epigenetic
control of mammalian gene expression, and is required
for X inactivation, genomics imprinting and silencing of
retrotransposons and repetitive sequences [1,2]. The loss
or the decrease of the 5-methylcytosine number on
DNA, i.e. the DNA hypomethylation process, is ones of
the earlier hallmarks described in neoplasia [3]. More-
over, several paper reports that the DNA hypomethyla-
tion is an oncogenic event leading the chromosomal
instability and the oncogenes expression [4,5]. Literature
also mentioned that the degree of DNA hypomethyla-
tion has been also associated with the tumor progres-
sion and with the prognosis of survival of patients
suffering of tumors [6]. Conjugated with the fact that
the DNA methylation abnormalities are potentially
reversible, all these points encouraged the development
of pharmacologic inhibitors of DNA methylation and
their use in anti-tumor therapies. Thus, the quantifica-
tion of degree of DNA methylation in cells appears as a
crucial point for its use in diagnosis, prognosis and the
evaluation of the response to treatments including DNA
methylation modulators.
Several technologies have been developed to measure
the degree of DNA methylation [7]. A first group of
technologies is focused around the use of methodologies
that can quantify the 5-methyl cytosines using reversed-
phase high performance liquid chromatography (RP-
HPLC), two dimensional thin layer chromatography
(2D-TLC), high performance liquid chromatography-
mass spectrometry (HPLC-MS), high performance capil-
lary electrophoresis (HPCE) and liquid chromatography-
electrospray ionization-tandem mass spectrometry
(LC-ESI-MS/MS) [8,9]. A second group of technologies
has been developed to quantify the global 5-methylcyto-
sine via the radiolabelling of CpG sites, ELISA method,
pyrosequencing, use of methyl-sensitive enzymes in
COBRA method for example [10,11]. Literature also
mentions a third group of technologies in which the
degree of DNA methylation is analyzed by measuring
the activity of enzymes catalyzing the DNA methylation:
the DNA methyltransferases [ 1 2 ] .H o w e v e r ,a l lt h e s e
methods require multiple steps of works and a sufficient
(and significant) quantity of cells initially, and this point
is not always possible especially by working with certain
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fact that the method here exposed is an indirect method
of quantification of DNA methylation, it provides the
possibility to estimate the DNA methylation status from
a weak quantity of biologic materiel such as stem cells
or primary cultured tumor cells for examples.
Results
The technology that we present here is based on the
detection of protein-protein interactions via the adapta-
tion of the proximity ligation in situ technology to the
context of DNA methylation [13]. Based on the demon-
stration that the interaction between Dnmt1 and PCNA
plays a crucial role into the DNA methylation inheri-
tance, we decided to monitor and quantify the Dnmt1/
PCNA interaction by proximity ligation in situ assay
(P-LISA) in cells [14,15]. As illustrated by the Figure 1A,
the principle of this assay is based on the staining of
Dnmt1 and PCNA proteins by two antibodies, which are
next revealed by secondary antibodies conjugated with
oligonucleotides. In presence of hybridization solution
and ligase, the two oligonucleotides form with PLA a cir-
c l ei nc a s eo fc l o s ep r o x i m i t yo fp r o t e i n si . e .D n m t 1a n d
PCNA, here. Then, polymerase and nucleotides partici-
pate to the formation of the rolling circle amplification,
which are visualized in red fluorescence. Pictures were
realized by using microscopy (Axiovert 200 M Zeiss, Le
Pecq, France) with ApoTome module. To take in consid-
eration the possible presence of chromatic aberration, we
have performed calibration with specific balls of calibra-
tion akin the P-LISA signal (Figure 1B). The signal being
inferior to the axial resolution and in order to reduce the
diffraction, we next decided to decovolve the image by
using the Huygens Essential software (Figure 1C). Next,
the Huygens’s decovovling is used with the “nipkow disk”
method. The decovolving makes it possible to solve a sig-
nal of low diameter and to increase the quality of the 3D
reconstitution. The 3D reconstitution is obtained by
using Amira.4.1.1 program.
By using ApoTome technology, we can visualize the
interactions of endogenous proteins Dnmt1 and PCNA
(Figure 1D). Moreover, the use of this method validated
the idea that the Dnmt1/PCNA interactions occur in
nucleus and permitted to quantify the number of inter-
action per nucleus.
To validate the possibility to use the Dnmt1/PCNA
P-LISA to evaluate the degree of DNA hypomethylation
in cells, we compared whether the number of Dnmt1/
PCNA interactions was correlated with the values of 5
mC number quantification (ELISA method) in non-
tumor and tumor breast cell lines. P-LISA and ELISA
experiments realized from non-tumor and tumor breast
cell lines revealed that that tumor cells (MDA-MD-231
and Cal-51) harbored less Dnmt1/PCNA interactions
and less 5-methycytosine (5 mC) than non-tumor cells
(MCF10A) (Figures 2A and 2B). In others terms, these
results suggest that the DNA is less methylated in
tumor cells than in non-tumor cells since tumors cells
harbored less Dnmt1/PCNA interactions. By plotting
the value of 5 mC and the number of Dnmt1/PCNA
interactions per nucleus against each other, it appears
that the level of 5 mC was correlated with the number
of Dnmt1/PCNA interactions per nucleus (Figure 2C).
To test the idea that the Dnmt1/PCNA interaction can
be used to estimate the level of global DNA methylation,
we analyzed the effect of DNA hypomethylating agents/
strategies on the Dnmt1/PCNA interactions. Thus, we
firstly monitored the 5 mC number and the Dnmt1/
PCNA interactions in cells harboring an increasing
Figure 1 Detection of endogenous Dnmt1/PCNA interactions
using P-LISA. (A) Schematic representation of the Dnmt1/PCNA
proximity ligation in situ assay (P-LISA). (B) Calibration of the
microscopy (Axiovert 200 M Zeiss, Le Pecq, France) with ApoTome
module. Left: picture of calibration performed with calibration balls
(4 μm, Vue X-Y, Molecular Probes F36909). Right: picture of
calibration performed with calibration balls (2.5 μm, Vue X-Z,
Molecular Probes F36909). Bleu and red were merged in lateral and
axial. (C) Decovolving of picture realized with calibration balls (140
nm). (D) Dnmt1/PCNA interactions were visualized in MCF10A cells.
Red dots symbolize Dnmt1/PCNA interactions. Nucleus/DNA are
stained in blue via the use of DAPI. Top left: ApoTome view, top
right: orthogonal view, bottom: 3D views.
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Page 2 of 8deficiency of Dnmt1 expression. For this purpose, we used
U251 cells and siRNA directed against Dnmt1. As illu-
strated by the Figure 3A, ELISA monitoring the Dnmt1
expression indicated that the Dnmt1 expression decreased
when the quantity of siRNA treating the cells increased.
ELISA assessing the 5 mC and P-LISA measuring the
Dnmt1/PCNA interactions revealed that the siRNA-
mediated decrease of Dnmt1 expression was correlated
with the decrease of 5 mC and with the decrease of
Dnmt1/PCNA interactions (Figure 3A). In addition, a
Pearson’s correlation test also showed a significant correla-
tion between the number of Dnmt1/PCNA interactions
and the number of 5 mC (r = 0.983, p = 0.0004) (Figure
3B). Secondly, we analyzed the effect of the 5-aza-2-deoxy-
cytidine treatment on the number of Dnmt1/PCNA inter-
actions and on the DNA methylation status in U251 cells.
In absence of toxic effect of our 5aza treatment, we
observed, in parallel, significant decreases of the number
of Dnmt1/PCNA interactions, of the DNA methylation
status and of the level of the Dnmt1 expression (Figure 4).
Through these two last experiments, we noted that the
decrease of the number of Dnmt1/PCNA interactions is
associated with the decrease of 5 mC under a context of
decrease of Dnmt1 expression.
Figure 2 Decrease of Dnmt1/PCNA interaction is associated with the decrease of the DNA methylation. (A) Dnmt1/PCNA P-LISA in non-
tumor cells (MCF10A) and in tumor cells (MDA-MD-231 and Cal-51). Red dots symbolize Dnmt1/PCNA interactions. Nucleus/DNA are stained in
blue via the use of DAPI. The number of Dnmt1/PCNA interactions is calculated from the analysis of 100 nuclei. (B) Evaluation of the degree of
DNA methylation in cells by using 5 mC-ELISA. (C) Correlation between the 5 mC (5-methylcyctosine) number and the number of Dnmt1/PCNA
interactions.
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Dnmt1/PCNA interactions and/or the degree of DNA
methylation, we now considered the condition increas-
ing the Dnmt1/PCNA interactions and/or the degree of
DNA methylation. Physiologically, the degree of DNA
methylation increases between the G1 and S phases of
the cell cycle since, after the DNA replication, the neo-
synthesized strand of DNA is methylated according to
the pattern of methylation of the parental strand in
order to promote the DNA methylation inheritance pro-
cess. Thus, we next analyzed the evolution of the degree
of DNA methylation and of the number of Dnmt1/
PCNA interaction when cells were in G1/G0 and S
phases of the cell cycle. For this purpose, U251 cells
were blocked in G0/G1 and S phases by using serum
deprivation and thymidine treatments after a first syn-
chronization by serum deprivation (Figure 5A). P-LISA
and 5 mC ELISA were realized in parallel to monitor
the number of Dnmt1/PCNA interactions and the
degree of DNA methylation. As illustrated by the
Figures 5B and 5C, we observed that the significant
increase of Dnmt1/PCNA interactions in S phase is
associated with the significant increase of the 5 mC
number (p = 0.0013 and p = 0.0188).
The degree of DNA methylation can also increase
when cells are performing de novo methylation by
Dnmt3. To aim this situation, we have used the U87-
pORF-Dnmt3a cells since we have already used these
cells to promote the methylation of the caspase-8 gene
[16]. Under this condition, we observed that the global
level of DNA methylation and the number of Dnmt1/
PCNA interactions unchanged 2-days after the cells
transfection (p = 0.7262 and p = 0.4918) (despite the
fact that the methylation level of caspase8 gene was
already increased at this point (p < 0.0001)), while we
observed an increase of the global level of DNA methy-
lation and of the number of Dnmt1/PCNA interactions
4-days after the cells transfection (p = 0.0292 and p =
0.0142) (Figure 5D). Interestingly, these data suggest
that the number of Dnmt1/PCNA interactions increases
Figure 3 siRNA-mediated down-expression of Dnmt1 promoted the decrease of Dnmt1/PCNA interactions and the decrease of 5 mC
in U251 cells. (A) Impact of the siRNA-Dnmt1 treatments on the expression of Dnmt1 (ELISA method according to our previous report [17]), on
the 5 mC (ELISA method) and on the number of Dnmt1/PCNA interactions (P-LISA method). siRNA-Dnmt1 (sc-35204, Tebu-Bio, France) (B)
Correlation between the 5 mC (5-methylcyctosine) number and the number of Dnmt1/PCNA interactions.
Hervouet et al. BMC Biotechnology 2011, 11:31
http://www.biomedcentral.com/1472-6750/11/31
Page 4 of 8in response to the Dnmt3a-induced increase of the
5 mC number. However, the Dnmt1/PCNA interactions
monitoring was not representative of the methylation
degree of the caspase-8 gene. Thus, these data suggest
that the Dnmt1/PCNA interactions monitoring is not
recommended to analyze the methylation of level of spe-
cific gene.
Discussion
In terms of methodology, all our data argue that the
Dnmt1/PCNA Proximity-Ligation In Situ Assay pre-
sented here should enable to reflect the degree of DNA
methylation in cells. Indeed, that its is following a DNA
hypomathylation strategy (inhibition of the Dnmt1
expression or treatment (5aza) or by comparing non
tumor cells with tumor cells, the number of Dnmt1/
PCNA interactions echoes the degree of DNA methyla-
tion. In addition this method being performed from
fixated cells, it is adapted for investigation realized from
weak quantity of biologic materiel (Stem cells, biopsies
samples...) on contrary to the majority of technologies
aiming at analyzing the degree of DNA methylation
(and mentioned into the introduction section). One
other advantage of this method is into the fact that it
does no require to transform the cells with plasmid or
to extract DNA or nuclear samples in order to perform
5 mC-ELISA, to measure of mMTase, for example. In
addition, our data indicate that it is not necessary to
take into consideration the expression level of Dnmt1
and/or PCNA since none correlation between the
Dnmt1 level expression and the 5 mC number was
observed in a large number of glioma and 2) since the
Dnmt1/PCNA interactions can be inhibited by other
events that the level expression of these proteins (such
as the phosphorylation of Dnmt1, the presence of pep-
tide/protein imitating the action of the UP peptide
[17,18].
Supported by these points, we thus envision a wide
range of applications for the Dnmt1/PCNA P-LISA in
basic research and into the development of DNA hypo-
methylation strategies based or not on the inhibition of
the complexes including the Dnmt1/PCNA interactions
such as the one including the Dnmt1/PCNA/UHRF1
w h i c hi sc o n s i d e r e da st h em a i np l a y e ro ft h eD N A
methylation inheritance.
In terms of biologic results, our data show that the
breast cancer cell lines (MDA-MD-231 and Cal-51) har-
bored less Dnmt1/PCNA interactions and less 5-methy-
cytosine (5 mC) than non-tumor breast cells (MCF10A).
Thus, breast cancer appears as the second, after glioma,
in which we observed that the DNA hypomethylation
characterizing the tumor cells is correlated with the
decrease of Dnmt1/PCNA interactions [17,18]. Besides,
the fact that DNA of breast cancer cells is hypomethyla-
tion in comparison with DNA of breast cells is a well-
documented point by the literature [19-21]. The fact
that the degree of DNA methylation is correlated with
the level of Dnmt1/PCNA interactions makes sense with
the fact that the Dnmt1 and PCNA, are two crucial
actors, with UHRF1, of the main multiprotein complex,
promoting the DNA methylation inheritance in mam-
malian cells [15,22]. In addition, our data indicate that
the Dnmt1/PCNA interactions are increased, such as
the DNA methylation level, during the S phase in com-
parison with the number of Dnmt1/PCNA interactions
and the DNA methylation level characterizing the G0/
Figure 4 Impact of the 5aza treatment on the DNA
methylation status (ELISA method), the number of Dnmt1/
PCNA interactions (P-LISA method) and on the Dnmt1
expression (ELISA method) in U251 cells.
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Page 5 of 8G1 phase. Thus, the use of the Dnmt1/PCNA P-LISA
confirms a dogma of epigenetic reporting that the DNA
methylation inheritance catalyzed by the complex
including the Dnmt1/PCNA interactions is a process
mainly realized during the S phase [15,22]. In addition,
the use of P-LISA could be interesting to monitor the
interactions existing between the Dnmt1 protein (the
main enzyme catalyzing the DNA methylation inheri-
tance) and different of its interaction partner during the
cell cycle. Besides, these investigations are an ongoing
subject in our lab and take place into the debate aiming
to characterize the dynamism and the kinetic of the
DNA methylation inheritance catalyzed by the Dnmt1
during the cell cycle. Our data also indicate that the
monitoring of the Dnmt1/PCNA interactions was not
representative of the increase of the methylation degree
of the caspase-8 gene following the Dnmt3a overexpres-
sion, but that at middle term (4-days) the number of
Dnmt1/PCNA interactions reflected the Dnmt3a-
induced increase of 5 mC. Thus, our data suggest that
Figure 5 Impact of conditions increasing the level of DNA methylation on the number of Dnmt1/PCNA interactions. (A) Characterization
cell cycle of arrest. U251 cells were treated by serum deprivation (72 h) or by thymidine (2 mM, 24 h), previous to perform cell cycle analysis by
using the NucleoCounter NC-3000™ Kit, Chemometec, France). (B) Dnmt1/PCNA P-LISA in U251 cells blocked in G0/G1 or S phases of the cell
cycle. Red dots symbolize Dnmt1/PCNA interactions. Nucleus/DNA are stained in blue via the use of DAPI. (C) Analysis of the number of Dnmt1/
PCNA interactions (P-LISA) and the 5 mC number (ELISA). The number of Dnmt1/PCNA interactions is calculated from the analysis of 100 nuclei.
(D) Impact of the Dnmt3a overexpression in U87 cells on the level of methylation of the capase-8 gene (MeDIP), on DNA (5 mC ELISA) and on
the number of Dnmt1/PCNA interactions. The number of Dnmt1/PCNA interactions is calculated from the analysis of 100 nuclei. U87-pORF-
Dnmt3a and the U87-pORF (transfection control (-)) were obtained as previously described [16].
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a method adapted to analyze the degree of methylation
o fas p e c i f i cg e n eb u ti sa d a p t e dt om o n i t o rt h ed e g r e e
of DNA methylation. In addition, the increase of
Dnmt1/PCNA interactions in Dnmt3a-induced up-
methylated cells was not associated with the Dnmt1 or
PCNA overexpression (data not shown). Thus, these
data suggest that, after a step of de novo methylation
catalyzed by the Dnmt3 in “mother cells”, “daughter
cells” could adapt the number of Dnmt1/PCNA interac-
tions to maintain the DNA methylation pattern realized
by the Dnmt3 in “mother cells”. Thus, there is an adap-
tation of the cells according its requirements of DNA
methylation inheritance and not according the relative
quantity of Dnmt1 and PCNA. This point impacts the
methodology of the use of the Dnmt1/PCNA P-LISA
for monitoring the global DNA methylation in cells
s i n c et h i ss u g g e s t st h a ti ti sn o tn e c e s s a r yt on o r m a l i z e
the counting of P-LISA to the protein level of Dnmt1
and PCNA.
Conclusion
The detection of the Dnmt1/PCNA interactions via the
proximity ligation in situ assay to the estimate the
degree of DNA methylation in cells appears as an attrac-
tive method since 1) it is applicable to a weak quantity
of cells, 2) it limits the number of protocol step (no
DNA extract, no transfection,...), 3) it reflects the fact
that cancer cells are hypomethylated in comparison with
no tumor cells, and 4) it echoes the effect of DNA hypo-
methylating agents/strategies.
Methods
Proximity ligation in situ assay
Cells were cultivated for 24 h on cover slip. Cells were
then fixed with 4% paraformaldehyde in PBS pH7.4 for
15 min at room temperature. Permeabilization is per-
formed with PBS containing 0.5% Triton 100 × 4 for 20
min at room temperature. Blocking, staining, hybridiza-
tion, ligation, amplification and detection steps were
realized according to manufacturer’s instructions (Olink
Bioscience). During these steps, all incubations were
performed in a humidity chamber. Amplification and
detection steps were performed in dark room. Fluores-
cence was visualized by using the Axiovert 200 M
microscopy system (Zeiss, Le Pecq, France) with Apo-
Tome module (X63 and numerial aperture 1.4). Prepara-
tions were mounted by using ProLong
® Gold antifade
reagent with DAPI (InVitrogen, France). Pictures acqui-
sition was realized in structured illumination microscopy
[23]. Thus, the lateral resolution (rl) is, according to the
Rayleigt criteria: rl = 0.61l/NA (l: wavelength; NA:
numerical aperture of the objective), and the axial
resolution, in ApoTome, is defined by the full-width half
maximum (FWHMz)
FWHM(z)=
3.83
16π
·
λ × 10−3
n · sin
2 α
2

¯ v

1 − ¯ v
2

In this equation, l is the emission wavelength, n is the
index of medium refraction, ν is the frequency and a is
the angle of opening of the objective as previously
described [24]. After decovolving (3.5 Huygens Essential
s o f t w a r e( S V I ) ) ,3 Dv i e ww a so b t a i n e db yu s i n g
Amira.4.1.1 program. Finally, the image were analyzed
by using the freeware “BlobFinder available for down-
load from http://www.cb.uu.se/~amin/BlobFinder. Thus,
we obtained either number of signals per nuclei since
nuclei can be automatically identified. In other terms,
the use of this program participates to the normaliza-
tion, standardization, reproducibility and to the defini-
tion of the cut off signal to accept/quantify or not a dot.
5methylcytosine ELISA (5 mC-ELISA) and Methylated DNA
ImmunoPrcipitation experiments (MeDIP)
DNA was extracted by using the QiaAmp DNA mini Kit
(Qiagen, France), and 5 mC-ELISA was performed by
using the Methylamp Global DNA Methylation Quanti-
fication kit (Epigentek-Euromedex, France). DNA
ImmunoPrecipitation (MeDIP) were performed by using
MethylCollector™ kit according to the manufacturer’s
instructions (Active Motif, France). qPCR were realized
to analyze the level of DNA methylation of a considered
gene with specific primers (s: CAGGAGGTGGAGG
TTGC andas: GAGCCCTAGACCCTCCC) and accord-
ing our previous report [17].
Genes invalidation experiments
Dnmt1 gene was invalidated by using siRNA approach
(sc35204, Tebu-Bio France) according to manufacturer’s
instructions. siRNA-A was used as control (sc37007,
Tebu-Bio France). Classical siRNA treatment (referred
as x1) was performed by using 60 pmols of considered
siRNA.
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